$2.44
-0.01-0.41%
Ult. Agg.: Oct 28, 9:29 AM
Pacific Biosciences (PACB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pacific Biosciences (PACB) ha pubblicato l'ultima guidance il agosto 5, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $155M - $165M per il periodo.
Rispetto alle previsioni precedenti, Pacific Biosciences ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Pacific Biosciences ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Pacific Biosciences. 14
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $-0.14 | $-0.16 | $-0.15 |
| Actual | $-0.14 | $-0.12 | $-0.12 | $-0.12 |
| Surprise | -7.69% | +14.3% | +25.0% | +20.0% |
| Revenue | ||||
| Estimate | $41.0M | $40.2M | $41.8M | $40.1M |
| Actual | $39.0M | $37.2M | $44.6M | $38.4M |
| Surprise | -4.79% | -7.48% | +6.73% | -4.10% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.12 | $-0.13 |
| Revenue | ||||
| Consensus | $39.1M | $42.8M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.14 | $-0.13 | -7.69 % |
| Q1 | May 7, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q4 | Feb 12, 2026 | $-0.12 | $-0.16 | 25.0 % |
| Q3 | Nov 5, 2025 | $-0.12 | $-0.15 | 20.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $39.01M | $40.97M | -4.79 % |
| Q1 | May 7, 2026 | $37.18M | $40.18M | -7.48 % |
| Q4 | Feb 12, 2026 | $44.65M | $41.83M | 6.73 % |
| Q3 | Nov 5, 2025 | $38.44M | $40.08M | -4.10 % |